《Pharmacogenomics & Personalized Medicine》是一本由DOVE MEDICAL PRESS LTD出版商出版的专业医学期刊，刊期1 issue/year，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 3区，小类学科：药学 3区；在JCR（Journal Citation Reports）分区等级为Q3。该刊发文范围涵盖药学等领域，旨在及时、准确、全面地报道国内外药学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为2.606，平均审稿速度16 Weeks。

Pharmacogenomics & Personalized Medicine英文介绍

Pharmacogenomics and Personalized Medicine is an international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.

In particular, emphasis will be given to:

Genomic and proteomic profiling

Genetics and drug metabolism

Targeted drug identification and discovery

Optimizing drug selection & dosage based on patient's genetic profile

Drug related morbidity & mortality intervention

Advanced disease screening and targeted therapeutic intervention

Genetic based vaccine development

Patient satisfaction and preference

Health economic evaluations

Practical and organizational issues in the development and implementation of personalized medicine programs.

Pharmacogenomics & Personalized Medicine中科院分区

大类学科	分区	小类学科	分区	Top期刊	综述期刊
医学	3区	PHARMACOLOGY & PHARMACY 药学	3区	否	否

Pharmacogenomics & Personalized Medicine期刊近9年JCR分区变化趋势

Pharmacogenomics & Personalized MedicineJCR分区(JCR2021-2022年分区)

JCR分区等级	JCR所属学科	分区	影响因子
Q3	PHARMACOLOGY & PHARMACY	Q3	2.606

Pharmacogenomics & Personalized Medicine期刊近7年影响因子变化趋势

Pharmacogenomics & Personalized Medicine期刊的CiteScore值(CiteScore2021-2022年CiteScore值)

CiteScore	SJR	SNIP	学科类别	分区	排名	百分位
3.00	0.683	0.977	大类：Pharmacology, Toxicology and Pharmaceutics 小类：Pharmacology	Q3	188 / 303	38%
3.00	0.683	0.977	大类：Pharmacology, Toxicology and Pharmaceutics 小类：Molecular Medicine	Q3	118 / 167	29%

Pharmacogenomics & Personalized Medicine期刊近7年自引率变化趋势

上周TOP10